Efficacy and Mechanism of Action of Danggui Niantong Decoction against Acute Gouty Arthritis in a Mouse Model:an Experimental Study
1.Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
2.Institute of Spinal Diseases,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
3.Shanghai Changning Tianshan Traditional Chinese Medicine Hospital,Shanghai 200051,China
4.Key Laboratory of Ministry of Education for Musculoskeletal Theory and Treatment,Shanghai 200120,China
5.School of Rehabilitation Science,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
6.Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China
*Corresponding author:LIANG Qianqian,Professor,Doctoral supervisor;E-mail:liangqianqiantcm@126.com
CHEN Shaohua,WANG Chinyun,WU Changgui, et al. Efficacy and Mechanism of Action of Danggui Niantong Decoction against Acute Gouty Arthritis in a Mouse Model:an Experimental Study [J]. Chinese General Practice, 2021, 24(24): 3116-3121. DOI: 10.12114/j.issn.1007-9572.2021.00.455.
陈绍华,王沁筠,吴昌桂等. 当归拈痛汤治疗急性痛风性关节炎疗效和作用机制的小鼠实验研究[J]. 中国全科医学, 2021, 24(24): 3116-3121. DOI: 10.12114/j.issn.1007-9572.2021.00.455.
[1]WILSON L,SASEEN J J.Gouty arthritis:a review of acute management and prevention[J].Pharmacotherapy,2016,36(8):906-922.DOI:10.1002/phar.1788.
[2]DALBETH N,MERRIMAN T R,STAMP L K.Gout[J].Lancet,2016,388(10055):2039-2052.DOI:10.1016/S0140-6736(16)00346-9.
[3]BARNETT R.Gout[J].Lancet,2018,391(10140):2595.DOI:10.1016/S0140-6736(18)31366-7.
[4]KHANNA D,KHANNA P P,FITZGERALD J D,et al.2012 American College of Rheumatology guidelines for management of gout.Part 2:therapy and antiinflammatory prophylaxis of acute gouty arthritis[J].Arthritis Care Res(Hoboken),2012,64(10):1447-1461.DOI:10.1002/acr.21773.
[5]KHANNA D,FITZGERALD J D,KHANNA P P,et al.2012 American College of Rheumatology guidelines for management of gout.Part 1:systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J].Arthritis Care Res(Hoboken),2012,64(10):1431-1446.DOI:10.1002/acr.21772.
[6]KUO C F,GRAINGE M J,ZHANG W,et al.Global epidemiology of gout:prevalence,incidence and risk factors[J].Nat Rev Rheumatol,2015,11(11):649-662.DOI:10.1038/nrrheum.2015.91.
[7]阎胜利,赵世华,李长贵,等.山东沿海居民高尿酸血症及痛风五年随访研究[J].中华内分泌代谢杂志,2011,27(7):548-552.DOI:10.3760/cma.j.issn.1000-6699.2011.07.002.
YAN S L,ZHAO S H,LI C G,et al.A five years follow up study on patients with gout and hyperuricemia[J].Chinese Journal of Endocrinology and Metabolism,2011,27(7):548-552.DOI:10.3760/cma.j.issn.1000-6699.2011.07.002.
[8]邹晋梅,杨静,董建玲,等.北川羌族人群高尿酸血症及痛风流行病学调查[J].当代医学,2011,17(31):12-14.DOI:10.3969/j.issn.1009-4393.2011.31.006.
[9]谭立夫,朱君,严妙娟,等.惠州市惠阳区2008~2014年痛风和高尿酸血症的流行病学调查[J].现代诊断与治疗,2016,27(10):1919-1920.
[10]黄家钿,周碧华,陈珊珊,等.宁波市社区人群痛风与高尿酸血症的现况研究[J].浙江预防医学,2013,25(7):8-10.DOI:10.3969/j.issn.1007-0931.2013.07.003.
[11]崔淑芬,魏合成,田志莲,等.张家口地区蔚县职工高尿酸血症和痛风的患病率调查[J].临床荟萃,2014,29(9):1028-1029.DOI:10.3969/j.issn.1004-583X.2014.09.22.
[12]PEREZ-RUIZ F,CALABOZO M,ERAUSKIN G G,et al.Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output[J].Arthritis Rheum,2002,47(6):610-613.DOI:10.1002/art.10792.
[13]ICHIDA K,MATSUO H,TAKADA T,et al.Decreased extra-renal urate excretion is a common cause of hyperuricemia[J].Nat Commun,2012,3:764.DOI:10.1038/ncomms1756.
[14]MARTINON F,PéTRILLI V,MAYOR A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasome[J].Nature,2006,440(7081):237-241.DOI:10.1038/nature04516.
[15]CRONSTEIN B N,SUNKUREDDI P.Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis[J].J Clin Rheumatol,2013,19(1):19-29.DOI:10.1097/RHU.0b013e31827d8790.
[16]中华医学会风湿病学分会.2016中国痛风诊疗指南[J].浙江医学,2017,39(21):1823-1832.DOI:10.3760/cma.j.issn.0578-1426.2016.11.019.
[17]NEOGI T.Clinical practice.Gout[J].N Engl J Med,2011,364(5):443-452.DOI:10.1056/NEJMcp1001124.
[18]REBER L L,GAUDENZIO N,STARKL P,et al.Neutrophils are not required for resolution of acute gouty arthritis in mice[J].Nat Med,2016,22(12):1382-1384.
[19]党万太,周京国,谢文光,等.不同中医证型痛风患者的临床指标对比分析及其意义[J].中国中西医结合杂志,2013,33(10):1323-1327.DOI:10.7661/CJIM.2013.10.1323.
[20]刘振葳,曲凡,牛莉,等.痛风中医证候学研究现状[J].中华中医药杂志,2019,34(6):2626-2628.
LIU Z W,QU F,NIU L,et al.Research status of traditional Chinese medicine syndrome on gout[J].China Journal of Traditional Chinese Medicine and Pharmacy,2019,34(6):2626-2628.
[21]沈维增,吕红梅,谢峥伟,等.当归拈痛汤对急性痛风性关节炎患者血IL-1、IL-8和TNF-α的影响[J].中国中医急症,2011,20(3):353-354,365.DOI:10.3969/j.issn.1004-745X.2011.03.004.
[22]戴凤翔,邱联群.当归拈痛汤联合西乐葆治疗急性痛风性关节炎的临床疗效观察[J].广州中医药大学学报,2020,37(3):422-425.DOI:10.13359/j.cnki.gzxbtcm.2020.03.008.
DAI F X,QIU L Q.Therapeutic efficacy of Danggui Niantong Decoction combined with celebrex for treatment of acute gouty arthritis[J].Journal of Guangzhou University of Traditional Chinese Medicine,2020,37(3):422-425.DOI:10.13359/j.cnki.gzxbtcm.2020.03.008.
[23]CHENG S,SUN H,LI X,et al.Effects of Alismatis Rhizoma and Rhizoma Smilacis Glabrae decoction on hyperuricemia in rats[J].Evid Based Complement Alternat Med,2019,2019:4541609.DOI:10.1155/2019/4541609.
[24]邢志华,马誉畅,李新萍,等.葛根素及其衍生物抗炎、抗痛风作用研究进展[J].中国中药杂志,2017,42(19):3703-3708.
XING Z H,MA Y C,LI X P,et al.Research progress of puerarin and its derivatives on anti-inflammatory and anti-gout activities[J].China Journal of Chinese Materia Medica,2017,42(19):3703-3708.
[25]MENG X,MAO Z,LI X,et al.Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice[J].Oncotarget,2017,8(25):40305-40317.DOI:10.18632/oncotarget.16928.
[26]钱伯初,史红,郑晓亮.尿酸钠结晶诱导痛风性关节炎动物模型研究进展[J].中国比较医学杂志,2008,18(6):65-69.DOI:10.3969/j.issn.1671-7856.2008.06.018.
QIAN B C,SHI H,ZHENG X L.Progress in research on animal models of urarthritis induced by monosodium urate[J].Chinese Journal of Comparative Medicine,2008,18(6):65-69.DOI:10.3969/j.issn.1671-7856.2008.06.018.
[27]REINWALD C,SCHAUER C,CSEPREGI J Z,et al.Reply to "Neutrophils are not required for resolution of acute gouty arthritis in mice"[J].Nat Med,2016,22(12):1384-1386.DOI:10.1038/nm.4217.
[28]LU J,DALBETH N,YIN H,et al.Mouse models for human hyperuricaemia:a critical review[J].Nat Rev Rheumatol,2019,15(7):413-426.DOI:10.1038/s41584-019-0222-x.